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Cerebral small-vessel damage manifests as white matter hyperintensities and cerebral
atrophy on brain MRI and is associated with aging, cognitive decline and dementia. We
sought to examine the interrelationship of these imaging biomarkers and the influence of
hypertension in older individuals. We used a multivariate spatial covariance neuroimaging
technique to localize the effects of white matter lesion load on regional graymatter volume
and assessed the role of blood pressure control, age and education on this relationship.
Using a case-control design matching for age, gender, and educational attainment
we selected 64 participants with normal blood pressure, controlled hypertension or
uncontrolled hypertension from the Northern Manhattan Study cohort. We applied gray
matter voxel-based morphometry with the scaled subprofile model to (1) identify regional
covariance patterns of graymatter volume differences associated with white matter lesion
load, (2) compare this relationship across blood pressure groups, and (3) relate it to
cognitive performance. In this group of participants aged 60–86 years, we identified a
pattern of reduced graymatter volume associated with white matter lesion load in bilateral
temporal-parietal regions with relative preservation of volume in the basal forebrain,
thalami and cingulate cortex. This pattern was expressed most in the uncontrolled
hypertension group and least in the normotensives, but was also more evident in older
and more educated individuals. Expression of this pattern was associated with worse
performance in executive function and memory. In summary, white matter lesions from
small-vessel disease are associated with a regional pattern of gray matter atrophy that is
mitigated by blood pressure control, exacerbated by aging, and associated with cognitive
performance.
Keywords: white matter hyperintensities, brain atrophy, hypertension, cerebrovascular disease, cognition, aging,
scaled subprofile model, voxel-based morphometry
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INTRODUCTION
White matter hyperintensities (WMH) observed on T2 MRI
are frequently discovered incidentally but are more prevalent
with increased age, hypertension, and other cerebrovascular risk
factors (Fazekas, 1989; DeCarli et al., 1995; de Leeuw et al., 2001).
Although, the origins ofWMHs are thought to be heterogeneous,
ischemic small-vessel disease is one established etiology (DeCarli
et al., 2005), and extensive lesions are associated with an
increased risk of stroke (Fazekas et al., 1993), gait disturbance
(Whitman et al., 2001), cognitive impairment and decline (de
Groot et al., 2000), and dementia (Barber et al., 1999).
Hypertension (Salerno et al., 1992), subclinical elevated blood
pressure (DeCarli et al., 1999), and WMH (Wen et al., 2006) are
also associated with reduced gray matter volume (GMV). WMH
and hypertension increase the risk of all-cause dementia (Barber
et al., 1999; Launer et al., 2000), Alzheimer’s disease (Hofman
et al., 1997), and are independently linked to cognitive decline
(van Swieten et al., 1991), with aspects of frontal lobe-mediated
executive functions, memory, and processing speed preferentially
affected (Junqué et al., 1990; Prins et al., 2005). Volumetric
studies have found frontal and temporal lobe atrophy associated
with WMH and aging (Raz et al., 2003; Raji et al., 2012), but
the complex relationship between WMH, gray matter atrophy,
cerebrovascular risk factors, and cognition is poorly understood.
Since cognitive changes in aging may be mediated by gray matter
loss (Raji et al., 2012), it is important to understand how WMH
relate to gray matter volume, and which risk factors modify this
relationship.
In this study we identify regional differences in GMV
associated with WMH lesion load in a group of cognitively
normal older adults and investigate the effects of blood pressure
control, age, sex, education, and overall intelligence on this
relationship, as well as examine the association between the
WMH-associated GMV (WMH∼GMV) pattern and domain-
specific cognitive performance.
METHODS
Participants
The Northern Manhattan Study (NOMAS) was designed to
determine stroke incidence, risk factors, and prognosis in a
race-ethnically diverse urban population. Study details have
been published previously. (Sacco et al., 1997) Briefly, eligible
participants were: (a) stroke-free; (b) greater than 40 years of age;
and (c) residents of Northern Manhattan for at least 3 months
in a household with a telephone and were enrolled between
1993 and 2001 (N = 3,298). Participants older than 50 years
who remained stroke-free were invited to participate in a brain
MRI substudy during annual telephone follow-up between 2003
and 2008. In addition, 199 household members of participants
that met all NOMAS inclusion/exclusion criteria were enrolled
to reach a total sample of 1,290. The study was approved by
the Institutional Review Boards of Columbia University and the
University of Miami and the protocol was designed and carried
out in accordance with their recommendations. All participants
provided informed written consent.
Sample Selection
For the current study, we identified 64 participants with
normotension, controlled hypertension or uncontrolled
hypertension. We obtained systolic and diastolic blood pressures
measured at the brachial artery while seated with a mercury
sphygmomanometer after a period of rest for 10min. Two
measurements were taken at least 1 h apart, and the values were
averaged. Participants with a reported history of hypertension
on antihypertensive medication were classified as having
controlled hypertension if the mean blood pressure was less
than 140 systolic and 90 diastolic. Participants were classified
as uncontrolled hypertension if they had a previous diagnosis
of hypertension and the mean blood pressure was greater than
140 systolic or 90 diastolic. Normotensive patients had no
history of hypertension and were not taking antihypertensive
medications. Groups were case-wise matched for age, sex, race,
and educational attainment. Participants were classified as
having finished 8th grade or less. The current study participants
were similar to and reflective of the overall NOMAS population.
Cognitive Assessment
Participants in the NOMAS MRI substudy were administered
a neuropsychological battery in either English or Spanish by
trained research assistants on the day of MRI acquisition. As
reported previously by Siedlecki et al. (2009) cognitive domains
were created using an exploratory factor analysis to group
tests with similar variance across a cohort of 796 participants
without cognitive impairment. The cognitive domains in this
study included memory, executive function, processing speed,
language, and general intellectual ability (Gc) (Siedlecki et al.,
2009). The neuropsychological tests used to represent each
cognitive domain are in keeping with recommendations from
the NINDS Canadian Stroke Network Vascular Cognitive
Impairment Harmonization Standards. The memory domain
was comprised of the components of a modified California
Verbal Learning Test. Executive function was assessed with the
Wechsler Adult Intelligence Scale letter-number sequencing test,
the digit ordering task, the odd-man-out task, and a difference
score from the Color Trails test (similar to Trailmaking Test
form B). Processing speed was evaluated with the Grooved
Pegboard task. Language (not previously reported) was assessed
with the Controlled Oral Word Association Task, the Animal
Naming test, and the Boston naming test. Finally, to estimate
Gc (Cattell, 1987) as a surrogate for premorbid IQ (Siedlecki
et al., 2009), we administered the Peabody Picture Vocabulary
Test. Subtest scores were converted into Z-scores for each of
the four domains based on the mean and standard deviation
of all participants of the NOMAS brain MRI substudy. A self-
reported depression scale, The Center for Epidemiologic Studies
Depression Scale (CESD), was available in 58 of 64 participants.
The CESD is a 20-question survey of depressive symptoms that
was developed in 1977 and has been used in diverse populations
for the epidemiologic study of depression (Radloff, 1977). ApoE
genetic testing was available for a subgroup of 58 of the 64
participants from fasting blood samples drawn at the time of
MRI. ApoE alleles were determined by HhaI digestion of PCR
products amplified from genomic DNA as described previously.
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Carriers of one or two alleles of ApoE-4 were collapsed into the
same category and compared against carriers of only ApoE-3 or
ApoE-2 (Hixson and Vernier, 1990; Willey et al., 2014).
Image Acquisition and Processing
Participants were scanned with a 1.5T scanner (Phillips, The
Netherlands). A 3D T1 structural image (slice thickness 1.5mm
no gap, TE 2.1ms, TR 20ms, flip angle 20◦) was acquired to
assess gray matter volume (GMV). A T2 FLAIR sequence (FOV
250mm, matrix 192 × 133 scaled to 256 × 256, slice thickness
3mm no gap, TE 144ms, TR 5,500ms, TI 1900ms, flip angle
90◦) was used to identify WMH, total brain volumes (TBV),
and total intracranial volumes (TIV), which were obtained using
a validated, automatic segmentation algorithm as previously
reported (DeCarli et al., 1992; Wright et al., 2005). GMV was
converted into a fraction of TBV (GMF) for comparison. WMH
volumes were converted into a percentage of TIV to correct
for head size, and then log transformed (logWMH) to use
in regression analyses, since raw volumes were not normally
distributed.
T1 images were processed using SPM8 (Wellcome
Department of Imaging Neuroscience, London, United
Kingdom; www.fil.ion.ucl.ac.uk/spm) Voxel Based
Morphometry (VBM) (Ashburner and Friston, 2000) software
to segment MRIs into gray matter, white matter and CSF
after image intensity nonuniformity correction. The DARTEL
(Diffeomorphic Anatomic Registration Through Exponentiated
Lie algebra) toolbox was used to create a group-specific brain
template aligned to a common MNI (Montreal Neurologic
Institute) space by iteratively aligning tissue segmentations
using a common tissue probability map. The gray matter maps
were processed to preserve volume information with the spatial
deformations. A 10mm smoothing kernel was applied and
statistics were performed on gray matter volume (GMV) maps
across the sample at each voxel.
We used the Scaled Subprofile Model (SSM) (Moeller
et al., 1987; Alexander and Moeller, 1994) to identify the
regional pattern of VBM GMV differences associated with
WMH load in the cohort. The SSM is a multivariate technique
that tests for regional covariance patterns in neuroimaging
scans without requiring conservative correction for multiple
comparisons on a voxel-wise basis. This analytic method has
been applied to numerous functional and structural imaging
studies with PET and MRI (Eidelberg et al., 1995; Alexander
et al., 1999; Smith et al., 2006). Applications to MRI VBM
have demonstrated sensitivity in identifying regional patterns of
gray matter changes related to aging and risk for Alzhiemer’s
disease (Alexander et al., 2006, 2008, 2012; Bergfield et al.,
2010).
In our study, we used VBM and SSM to identify a pattern of
GMV variability associated with logWMH volume and created
a set of SSM subject scores that reflect the extent to which
each individual expresses this WMH-related gray matter volume
(WMH∼GMV) pattern. Individual subject scores were used in
subsequent group analyses.
The SSM analysis was performed using MATLAB (Math
Works, Natick, Massachusetts, USA). GMV images were
smoothed and log transformed, and means across regions
and participants were subtracted at each voxel. A Principal
Component Analysis was performed to decompose the dataset
into gray matter network components that explain the greatest
variance in the neuroimaging data. To select the linear
combination of gray matter network components that best
model the variance in WMH across the cohort, we used the
Akaike Information Criterion (AIC) (Burnham and Anderson,
2002) with multiple-regression. The first subset of components
that together mapped the lowest AIC value in the regression
model to identify the WMH∼GMV network was selected as
the best set of component predictors. Total intracranial volume
(TIV) was included as a covariate to account for differences
in head size as previously described (Bergfield et al., 2010).
To provide reliability estimates of the resulting WMH∼GMV
pattern, we used bootstrap resampling with 500 iterations of the
SSM multivariate regression, and used the means and standard
deviations to calculate a Z-score at each voxel (Alexander et al.,
2012). Thresholding at Z ≤ −2 and Z ≥ 2 created Z-maps
identifying areas of GMV differences robustly associated with
logWMH.
Statistics
Group differences were determined using ANOVA and chi-
squared tests. Individual subject scores were calculated from
the SSM multivariate regression that reflect the extent to
which each participant expresses the WMH∼GMV pattern.
These values were used to compare the strength of the
WMH∼GMV association between uncontrolled hypertensive,
controlled hypertensive, and normotensive participants using
ANCOVA and ordinal linear regression while controlling for
age and educational level. We tested the effects of age, sex,
educational attainment and Gc on this relationship using
multivariate linear regression. We also tested the association
between expression of the WMH∼GMV pattern and cognitive
performance using multivariate regression models that included
the pattern subject scores and cognitive domain Z-scores for
memory, executive function, processing speed, and language
while controlling for age and level of education. A conservative
bonferroni correction was applied to these 4 multivariate linear
regression models for multiple comparisons and the corrected p-
values reflect this. All tests were two-tailed and an alpha of 0.05
determined significance.
RESULTS
Participants included 64 adults ranging from 60 to 86 years of age
(mean = 72 years). Twenty-two had uncontrolled hypertension,
21 had controlled hypertension, and 21 were normotensive.
Groups were matched case-wise for age, sex, race and education.
There were no differences between the study participants and the
overall NOMAS population in age, ethnic distribution, smoking
status, diabetes status, cognitive scores or CESD. There were no
group differences in Gc or performance in each of the cognitive
domains. Mean cognitive Z-scores were close to zero for each
group and the mean of the four cognitive domains was greater
than −1.5 for each participant, indicating a level of cognitive
function representative of the NOMAS study without significant
cognitive impairment. There were no group differences in GMF,
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WMH volume, or total brain volume (TBV) after adjusting for
head size with TIV. (Table 1)
Normotensive participants were not on antihypertensive
medications. In the controlled hypertension group, all
participants were on at least one antihypertensive medication
and 5 participants were on 2 antihypertensives. In the
uncontrolled hypertensive group, 9 participants were not
on antihypertensive medication, 6 were on one antihypertensive,
6 were on 2 antihypertensives, and 1 was on 3 antihypertensives
(Supplementary Table). The distribution of antihypertensive
medication class was not different between the participants with
controlled and uncontrolled hypertension.
More educated participants had better executive function
and language scores (p < 0.0001) and tended to have non-
significantly better memory (p = 0.07) and processing speed (p
= 0.10) than those with less education. Participants with higher
education had a trend for greater WMH load (p = 0.07) but no
differences in adjusted TBV.
Gray matter VBM in combination with SSM and AIC
identified the best linear combination of topographical GMV
component patterns associated with WMH volumes in the
sample. This model included components 1, 2, and 6 and
accounted for 34.5% of the variance in logWMH (R = 0.613,
adjusted R2 = 0.345; Figure 1). The WMH∼GMV pattern
included reduced GMV in the superior temporal gyri bilaterally,
the left angular gyrus, and bilateral supramarginal and orbital
gyri. GMV was relatively greater in the cingulate cortex
bilaterally, the medial thalami and the basal forebrain (Figure 2).
In comparing blood pressure control groups, the uncontrolled
hypertensive group had the greatest expression of the
WMH∼GMV pattern (as indicated by the highest pattern
subject scores), while the normotensive group had the lowest
expression after adjusting for age, gender, education and Gc.
The expression of the WMH∼GMV pattern was significantly
greater in the uncontrolled hypertensive group compared to
the normotensive group (ANCOVA: Main effect of group:
F-statistic = 4.497, degrees of freedom (dof) = 2, p = 0.015),
while the difference between uncontrolled hypertensive and
controlled hypertensive groups, as well as the difference between
controlled hypertensive and normotensive groups were not
significant (Figure 3A). Using ordinal regression we tested the
linear association between the WMH∼GMV pattern and blood
pressure group while covarying for age and education and
FIGURE 1 | Subject scores calculated from the Scaled Subprofile
Model (SSM) gray matter volume covariance pattern predict log of
white matter hyperintensity (WMH) volume across the cohort.
TABLE 1 | Clinical Characteristics.
Total Normotensives Controlled hypertensives Uncontrolled hypertensives P-values*
N 64 21 22 21
Age in years mean ± SD 72 ± 7 72 ± 7 71 ± 8 71 ± 7 0.80
Males:Female 21:43 7:14 7:15 7:14 0.99
never:former:current smoker 31:26:7 10:10:1 9:9:4 12:7:2 0.57
# with Diabetes 14 3 5 6 0.53
# with PVD 10 1 5 4 0.24
# with < 8th grade Education 35 12 12 11 0.95
IQ Z-score mean ± SD 0.08 ± 0.81 0.13 ± 0.97 0.06 ± 0.80 0.06 ± 0.68 0.95
Memory Z-score mean ± SD 0.07 ± 0.79 0.03 ± 0.88 0.15 ± 0.75 0.03 ± 0.73 0.85
Executive Function Z-score mean ± SD –0.14 ± 0.81 –0.12 ± 0.84 –0.07 ± 0.80 –0.24 ± 0.81 0.80
Processing Speed Z-score mean ± SD 0.01 ± 0.35 –0.03 ± 0.30 0.07 ± 0.40 –0.02 ± 0.34 0.54
Language Z-score mean ± SD 0.01 ± 0.75 0.15 ± 0.89 –0.01 ± 0.69 –0.11 ± 0.67 0.54
Total Cerebral Volume cc ± SD 1138 ± 118 1137 ± 99 1130 ± 118 1146 ± 139 0.91
Gray Matter Fraction ± SD 0.56 ± 0.02 0.57 ± 0.02 0.56 ± 0.02 0.56 ± 0.02 0.75
WMH Volume cc mean ± SD 7.7 ± 9.1 5.6 ± 7.7 9.0 ± 8.3 8.4 ± 11.1 0.45
WMH Brain Fraction mean ± SD %† 0.66 ± 0.73 % 0.48 ± 0.61% 0.78 ± 0.70% 0.70 ± 0.85% 0.38
WMH, white matter hyperintensities; SD, standard deviation; PVD, peripheral vascular disease.
*P-values reflect Chi-squared test for gender, smoking, diabetes, PVD, and education, One-way ANOVA for all others.
†
Total WMH Volume/Total Intracranial Volume.
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FIGURE 2 | Gray Matter Volume (GMV) Covariance Pattern predicting log of white matter hyperintensity (WMH) volume across the entire cohort. Color
bars depict Z-scores. Blue shows areas of reduced GMV Z ≤ −2 associated with greater WMH while red shows relative volume preservation with Z ≥ 2.
confirmed that blood pressure group predicted expression of
the WMH∼GMV pattern (B = 0.281, adjusted R2 = 0.064, p =
0.024). Neither sex nor Gc showed a significant association with
the WMH∼GMV pattern.
The WMH∼GMV pattern was expressed more in older
participants (main effect F-statistic = 26.627, dof = 1, p <
0.001), but there was no age by blood pressure group interaction
(Figure 3B). Participants with higher education also had greater
expression of theWMH∼GMV pattern (main effect F-statistic=
7.138, dof = 1, p = 0.01), but there was no education by group
interaction (Figure 3C).
Using multivariate linear regression, both increasing age (B=
0.504, adjusted R2 = 0.242, p < 0.001) and greater educational
attainment (B = 0.289, adjusted R2 = 0.069, p = 0.021) were
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FIGURE 3 | (A) Expression of the white matter hyperintensity-associated gray
matter volume (WMH∼GMV) pattern differs across blood pressure control
groups while covarying for age and educational attainment. Boxplot depicts
entire range (error bars), 1st quartile, median, and 3rd quartile. (B) Main effect
of age on blood pressure group x WMH∼GMV pattern expression. (C) Main
effect of education on blood pressure group x WMH∼GMV pattern expression
interaction. Error bars show 95% confidence intervals (B,C).
associated with greater expression of the WMH∼GMV pattern
despite having preserved cognitive performance.
Greater expression of the WMH∼GMV pattern was also
associated with worse memory (B=−0.277, p= 0.012, corrected
p = 0.048) and executive function (B = −0.315, p = 0.004,
corrected p = 0.016) while adjusting for age and education
(Figure 4). However, WMH∼GMV pattern expression was not
associated with processing speed, or language scores. Lower GMF
was also independently associated with worse memory (R= 0.42,
p = 0.01), but not executive function, language or processing
speed. Cognitive scores were not associated with logWMH or
adjusted TBV.
In the subgroup of 58 participants with CESD scores
(20 normotensive, 19 controlled hypertensive, 19 uncontrolled
hypertensive), depressive symptoms were not associated with
WMH, TBV, expression of WMH∼GMV pattern, or any of the
cognitive domains.
APOE genetic testing was available on 58 of the 64
participants. Twenty-eight percent have at least 1 APOE-4 allele.
There were more APOE-4 alleles in the normotensive group
(normotensive 7/17, controlled hypertensives 6/21, uncontrolled
hypertensives 3/20). Using logistic regression, APOE-4 status was
not significantly associated with brain volume, WMH volume,
expression of the WMH∼GMV pattern, or any of the cognitive
domains.
DISCUSSION
Using a multivariate neuroimaging approach incorporating both
gray and white matter imaging techniques, we identified a pattern
of GMV differences associated with WMH lesion load in a group
of older adults without significant cognitive impairment. Areas of
relatively smaller cortical GMV in the bilateral superior temporal
and temporal-parietal junctions as well as the orbital cortex may
reflect brain regions particularly sensitive to the effects of small-
vessel disease. Our finding that this WMH∼GMV relationship
was strongest in patients with uncontrolled hypertension, and
weakest in normotensives supports this conclusion. Previous
studies found that uncontrolled blood pressure predisposes
to white matter disease, (van Swieten et al., 1991; de Leeuw
et al., 2002) and that successful treatment reduces the risk
of developing white matter lesions. (Liao et al., 1996) In our
study, group differences in WMH volume or TBV were not
significant nor predictive, but we identified a regional pattern of
GMV differences associated with WMH that provides a potential
mechanism for the link between poor blood pressure control,
gray matter atrophy and age-related cognitive changes. (Nagai
et al., 2008) Other studies have also demonstrated associations
between WMH and GM atrophy (Appelman et al., 2009). Raji
et al. (2012) found an association between WMH and GMV
in a similar pattern involving the frontal and temporal-parietal
regions independent of age. We find that poor blood pressure
control augments the effect of WMH on GM atrophy, even
without differences in WMH volume or TBV.
We also identified areas of relative brain volume preservation
across the cingulate gyrus, the basal forebrain and the thalamus
that reflect regions less affected by cerebral small-vessel
disease, or perhaps indicate areas more strongly influenced
by non-vascular mechanisms such as amyloid deposition. In
a VBM study of mild cognitive impairment and Alzheimer’s
disease patients without cardiovascular disease or extensive
cerebrovascular disease, Karas et al. demonstrated both thalamic
and cingulate cortex atrophy compared to healthy controls
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FIGURE 4 | Subject scores for the white matter hyperintensity-associated gray matter volume pattern predicts (A) memory function Z-score (B = −0.277,
p = 0.012) and (B) executive function Z-score (B = −0.315, p = 0.004) after adjusting for age and educational attainment.
(Karas et al., 2004). However most studies identify extensive
overlap between risk factors for Alzheimer’s disease and WMH.
Some theorize that amyloid deposition and vascular damage
may act synergistically in the clinical manifestation of dementia
(Erten-Lyons et al., 2013; Provenzano et al., 2013).
The effect of age on the WMH∼GMV relationship reveals
that older individuals may be more susceptible to brain
atrophy resulting from small-vessel disease. Indeed previous
studies found differential effects of both hypertension and
age (Appelman et al., 2009) as well as interactions between
them (Strassburger et al., 1997; Raji et al., 2012). Arteriolar
sclerosis that occurs with both high blood pressure and
aging of the vascular system likely underlies endothelial
dysfunction, reduced vasoreactivity, and subsequent ischemia.
Chronic ischemia results in both demyelination and possibly
Wallerian degeneration (Appelman et al., 2009). The deleterious
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effects of these vascular changes on GM is less clear, in
part because imaging modalities sensitive to WMH are not
sensitive to GMV changes. While our findings are cross-
sectional, these data raise the possibility that better blood
pressure control could prevent cortical atrophy, especially
in older individuals, and prospective studies are needed to
directly test this hypothesis. The ongoing SPRINT-MIND
trial (Systolic Pressure Intervention Trial) may help in this
regard (ClinicalTrials.gov: NCT01206062). Meanwhile, evidence
from the Systolic Hypertension in Europe (Syst-Eur) trial
demonstrated that antihypertensive treatment reduced the
incidence of dementia (Forette et al., 1998).
The expression of aWMH∼GMVpattern is clinically relevant
in our study since it was associated with cognitive performance,
while neither WMH volume nor adjusted TBV showed such a
relationship. Greater expression of the WMH∼GMV pattern,
after adjusting for age and education, predicted lower memory
and executive function scores, despite our sample being
cognitively intact overall. This finding is consistent with previous
studies showing an association between memory function and
both white (de Groot et al., 2000) and gray matter insult (DeCarli
et al., 1995). Raji et al. (2012) concluded that while hypertension
was associated with WMH, the cognitive effects of hypertension
may be mediated by gray matter atrophy. The association in our
study with executive function was even stronger after adjusting
for age and education, which is also consistent with previous
studies (DeCarli et al., 1995; Prins et al., 2005). Executive
dysfunction has previously been associated with age, frontal lobe
atrophy and frontal lobe WMH, and has been implicated as a
marker for vascular cognitive impairment (Salthouse et al., 2003;
Wright et al., 2008). By using a multivariate analysis of structural
T1 and T2 differences, we identified a potential neuroimaging
biomarker that may be more sensitive to early changes in
domain-specific cognition in the elderly than conventional
measures such as WMH or TBV alone. Longitudinal studies
could evaluate this pattern as a biomarker for cognitive decline in
aging. In contrast to previous studies (Ylikoski et al., 1993; Prins
et al., 2005) we did not find WMH to be predictive of processing
speed, but we were limited to only one processing speed test with
low inter-subject variance.
In this community-based sample of older participants with
preserved cognition, we found that those with more education
had a trend for greater WMH load and significantly greater
expression of WMH-associated cerebral atrophy, despite similar
cognitive performance. These findings support the idea that
education contributes to cognitive reserve, wherein cognitive
function is preserved despite structural deterioration (Stern,
2002; Bennett et al., 2003). Cognitive reserve relates to lifestyle
characteristics including higher education and occupational
complexity (Stern et al., 1995; Bennett et al., 2003; Le Carret
et al., 2003), and is thought to reflect greater efficiency in
cognitive processes, permitting greater resistance to structural
insult. Reserve may also reflect adaptive neural processes and
recruitment of additional or more extensive brain areas to
circumvent structural pathology (Stern, 2002). Alternatively,
genetic predisposition responsible for cognitive resilience may
instead permit higher educational attainment.
There are several limitations to this study. We used WMH
volume, a summary measure for global white matter damage
reflective of small-vessel disease. While easily acquired on
commonly available clinical MRI scans, FLAIR WMH are
associated with heterogeneous underlying histopathology: from
mild perivascular tissue damage surrounding lipohyalinotic
arterioles with minimal axonal loss, to more severe ischemic
damage with extensive myelin and axonal loss (Gouw et al.,
2008). We emphasized hypertensive vascular risk in this study,
but WMH may also result from other factors including
Alzheimer’s disease, alcoholism or head trauma. Furthermore,
regionalWMHdistributionmay affect the sensitivity of detection
on MRI, as well as alter the extent and pattern of cognitive
impairment. Future studies using diffusion tensor imaging may
elucidate the link between regional WM insult, gray matter
atrophy, cerebrovascular risk factors, and cognition. Finally,
we highlight the importance of blood pressure control on
preventing brain structural changes associated with cognitive
decline. However, our cross-sectional study cannot fully evaluate
the effect of the duration of blood pressure control. Nor is it
powered to assess the class effects of different antihypertensive
medications. Larger longitudinal studies are needed to evaluate
optimization of blood pressure treatment to limit structural and
cognitive changes.
CONCLUSIONS
We evaluated a race-ethnically diverse, community-based
population of older adults without cognitive impairment. In
doing so we avoided the selection bias of hospital or referral
based studies but controlled many of the known risk factors for
WMH, gray matter atrophy, and cognitive decline by matching
groups for age, sex, and education to focus primarily on the
effects of blood pressure control on these outcomes. Rather
than assess WM or gray matter pathology alone, we used an
integrative, multivariate approach that evaluated modifiers of a
structural relationship between GMV and WMH, as a marker
of cerebral small-vessel disease. We identified a pattern of
WMH∼GMV differences that was sensitive to the effects of
blood pressure control and predictive of cognitive performance.
We conclude that controlling blood pressure may limit the
effects of small-vessel disease and aging on cerebral gray matter
atrophy, potentially delaying or preventing the onset of cognitive
sequelae.
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